A 54-year-old female patient has had diabetes for over 10 years and has been taking oral hypoglycemic medications.
A month ago, a trophic ulcer appeared on the first toe of the foot, which progressed to gangrene with inflammation of the subcutaneous fat tissue around the periphery. The surgeon proposed an operation to remove the entire foot, and possibly, if circulation in the lower leg was poor, amputation up to the popliteal fossa. The patient categorically refused the operation.
Treatment with infrared (IR) emitters was initiated. The affected limb was treated with GI and RV emitters for 10–20 minutes twice a day. On the third day of treatment, ZB was added for 3–5 minutes on the affected area and 10 minutes twice a day on the lower leg.
Additionally, KL-s emitters were applied to the pancreas for 5 minutes in two projections.
As a result of the therapy, the patient began experiencing pain (before treatment, she had no sensation in the affected limb), and the signs of inflammation around the gangrene focus significantly decreased. Amputation was limited to the gangrenous area, as circulation in the leg and foot vessels remained normal.
No side effects were observed.
Comments:
For all patients with diabetic foot lesions, GI and ZB emitters are used (GI destroys pathogenic bacteria, while ZB improves microcirculation). Treatment should begin as early as possible, increasing exposure to 40–60 minutes three to four times a day. If the clinical picture is favorable, surgical intervention can be postponed. Standard wound care and surgical removal of necrotic tissue are performed.
A month ago, a trophic ulcer appeared on the first toe of the foot, which progressed to gangrene with inflammation of the subcutaneous fat tissue around the periphery. The surgeon proposed an operation to remove the entire foot, and possibly, if circulation in the lower leg was poor, amputation up to the popliteal fossa. The patient categorically refused the operation.
Treatment with infrared (IR) emitters was initiated. The affected limb was treated with GI and RV emitters for 10–20 minutes twice a day. On the third day of treatment, ZB was added for 3–5 minutes on the affected area and 10 minutes twice a day on the lower leg.
Additionally, KL-s emitters were applied to the pancreas for 5 minutes in two projections.
As a result of the therapy, the patient began experiencing pain (before treatment, she had no sensation in the affected limb), and the signs of inflammation around the gangrene focus significantly decreased. Amputation was limited to the gangrenous area, as circulation in the leg and foot vessels remained normal.
No side effects were observed.
Comments:
For all patients with diabetic foot lesions, GI and ZB emitters are used (GI destroys pathogenic bacteria, while ZB improves microcirculation). Treatment should begin as early as possible, increasing exposure to 40–60 minutes three to four times a day. If the clinical picture is favorable, surgical intervention can be postponed. Standard wound care and surgical removal of necrotic tissue are performed.